|1.||Martin, Roger: 1 article (03/2015)|
|2.||Prise, Kevin M: 1 article (03/2015)|
|3.||Burdak-Rothkamm, Susanne: 1 article (03/2015)|
|4.||Lobachevsky, Pavel: 1 article (03/2015)|
|5.||Smith, Andrea: 1 article (03/2015)|
|6.||Raviraj, Jayam: 1 article (01/2014)|
|7.||Vasin, Mikhail V: 1 article (01/2014)|
|8.||Suman, Venkata: 1 article (01/2014)|
|9.||Reddy, Uday Shankar: 1 article (01/2014)|
|10.||Kumar, Venkata Suneel: 1 article (01/2014)|
08/01/1986 - "Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors."
11/01/2013 - "Rasayana drugs from the Ayurvedic system of medicine as possible radioprotective agents in cancer treatment."
03/01/2013 - "The use of radioprotective drugs may decrease the damage caused by radiation therapy and therefore could be useful to prevent the development of thyroid tumors. "
08/01/2003 - "The paper describes the possibilities of using radioprotective drugs, especially amifostin, in the therapy of tumors with particular emphasis to the needs of physicians dealing with the problems of internal medicine."
10/01/1986 - "The development of a labelled antibody for radioimmunoscintigraphic tumor localisation necessitates a major optimisation procedure to carefully balance factors such as radionuclide, anchoring site on the antibody, method of labelling and addition of radioprotective agents. "
|2.||Radiation Injuries (Radiation Sickness)
07/01/1995 - "Efficacy of radioprotective agents in preventing small and large bowel radiation injury."
03/01/1968 - "[The effect of radiation-protective agents on the blood coagulation process in acute radiation sickness in guinea pigs]."
09/01/2001 - "Furthermore, they explore the roles that target, host, and dosage factors play in hypersensitivity to radiation injury, the detection of these factors before treatment, and the administration of radioprotective agents. "
09/01/1977 - "[Toxicity and side effects of antibiotics in radiation sickness and during the use of aminothiol group radioprotective agents]."
03/31/1972 - "Noncytokinetic radiation injury: anticoagulants as radioprotective agents in experimental radiation hepatitis."
06/01/1990 - "However, these results have demonstrated that certain radioprotective drugs can induce marrow hypoxia and this reduced pO2 may contribute to the efficacy of these agents."
06/01/1989 - "Induction of marrow hypoxia by radioprotective agents."
11/01/2012 - "This fact allowed us to assume that the radioprotective effect of S-substituted ITU caused inhibition of the endogenous synthesis of NO, which promotes the development of circulatory hypoxia, and that a further search for the radioprotective agents in this class of chemicals should be considered as the search for effective inhibitors of NO-synthase (NOS). "
05/01/1985 - "The dependence of DMF upon oxygen concentration in the mixture was approximated by a hyperbolic function similar to the dependence of the radiomodifying effect of circulatory hypoxia caused by radioprotective agents of the indolylalkylamine series."
02/01/1966 - "[The effect of radiation-protective agents (anoxia, cysteamine and cystamine) on the sulfhydryl group content of Ehrlich ascites tumor cells]."
01/01/2007 - "A variety of preventive approaches for postirradiation xerostomia exist, involving more conformal radiation delivery technology, radioprotective agents, and even preirradiation surgical techniques. "
07/01/2004 - "Mice treated with both radioprotective agents (MnSOD-PL and WR2721) demonstrated a significant decrease in irradiation-induced xerostomia (measured as reduced salivary gland output volume), mucosal ulceration and improved survival. "
|5.||Head and Neck Neoplasms (Head and Neck Cancer)
07/01/2004 - "Enhanced salivary gland function in WR2721-treated mice in the absence of detectable mucosal protection, coupled with relatively low uptake of HA-MnSOD in the salivary glands of intraorally-treated mice, suggests that a combination of both radioprotective agents may prove optimally effective for the prevention of the acute and late normal tissue toxicities of fractionated radiotherapy for head and neck cancer."
|3.||DNA (Deoxyribonucleic Acid)
|5.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|6.||Nitric Oxide Synthase (NO Synthase)
|8.||Glutathione (Reduced Glutathione)
|9.||Dimethyl Sulfoxide (DMSO)